prof. Valerie Fonteyne
- ORCID iD
- 0000-0001-6724-1595
Show
Sort by
-
Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial.
-
- Journal Article
- A1
- open access
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice
-
- Journal Article
- A1
- open access
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort
-
PI-RADS 5 in Prostate Magnetic Resonance Imaging: how important is intraprostatic invasive behavior?
(2024) -
Success rate of In-Bore MRI-Guided Prostate Biopsy Based on Radical Prostatectomy and/or Follow-Up
(2023) -
Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?
(2023) -
- Journal Article
- A1
- open access
Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy?
-
Microbiome and metabolome dynamics during radiotherapy for prostate cancer
-
- Journal Article
- A2
- open access
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
-
- Journal Article
- A1
- open access
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer